| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/20/1992 | WO1991018599A3 1,4-dihydropyridines for application in combatting resistance to drugs |
| 02/19/1992 | EP0471612A2 New steroids having an amide substituted group in the 11-beta position, their preparation, their use as medicines and pharmaceutical composition thereof |
| 02/19/1992 | EP0471516A1 Tricyclic heterocyclic derivatives |
| 02/19/1992 | EP0471205A1 Monoclonal antibodies which bind TRK proto-oncogene protein |
| 02/19/1992 | CN1058781A Pyrano heterocyclic anthracycline analogs |
| 02/19/1992 | CN1058715A Solid oral forms of application containing ifosfamide as active substance |
| 02/18/1992 | US5089523 Fluorinated derivatives of mevinic acids |
| 02/18/1992 | US5089499 Anticarcinogenic agents; thymidylate synthetase inhibitors; antiallergens; psoriasis |
| 02/18/1992 | US5089476 Glutamic acid derivatives |
| 02/18/1992 | US5089400 Recombinant DNA which produces lymphoblastoid interferon-like polypeptides, useful as immunomodulators |
| 02/18/1992 | US5089249 Conjugates for bone imaging and bone cancer therapy |
| 02/18/1992 | CA1295998C Nucleosides and their use as antineoplastic agents |
| 02/18/1992 | CA1295946C Therapeutic agent containing tamoxifen for use in treatment of psoriasis |
| 02/18/1992 | CA1295944C Pharmaceutical composition with antiviral or antitumor activity |
| 02/18/1992 | CA1295940C Therapeutic treatment of abnormal cell growth with follicle regulatoryprotein |
| 02/17/1992 | CA2048510A1 Anthracycline compounds having anti-tumour activity, novel intermediates for the preparation of these anthracycline compounds, as well as compositions containing said active anthracycline compounds |
| 02/17/1992 | CA2048298A1 Tricyclic heterocyclic derivatives |
| 02/16/1992 | CA2048244A1 Monoclonal antibodies which bind trk proto-oncogene protein |
| 02/15/1992 | WO1992003144A1 Protein structure of the plant toxin gelonin |
| 02/15/1992 | CA2049102A1 19-nor-steroids with a carbon chain in 11-beta containing an amido group, preparation thereof, their application as drugs and pharmaceutical compositions containing them |
| 02/14/1992 | WO1992003129A1 Methods for inducing cell differentiation using ceramides |
| 02/14/1992 | CA2089001A1 Methods for inducing cell differentiation using ceramides |
| 02/13/1992 | DE4024885A1 Verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on Use of 2-phenyl-1,2-benzisoselenazol-3 (2H) -one |
| 02/12/1992 | EP0470586A1 Purified recombinant interleukin-2 compositions |
| 02/12/1992 | EP0470569A1 Intravascular embolizing agent containing angiogenesis inhibiting substance |
| 02/12/1992 | EP0470490A1 Substituted pyrroles |
| 02/12/1992 | EP0470144A1 Beta-hydroxamate d-aspartic acid for treatment of viral infections and tumours. |
| 02/12/1992 | CN1058598A New linker for bioactive agents |
| 02/11/1992 | US5087743 Treatment of skin disorders |
| 02/11/1992 | US5087712 Derivatives of platinum (ii) with polymethylsiloxane, method for preparing same and antitumor agent based thereon |
| 02/11/1992 | US5087637 Skin disorders |
| 02/11/1992 | US5087636 Method to destroy malignant cells in mononuclear cell populations |
| 02/11/1992 | US5087617 Methods and compositions for treatment of cancer using oligonucleotides |
| 02/11/1992 | US5087616 Linked by biodegradable polymer to epidermal growth factor |
| 02/11/1992 | US5087560 Monoclonal antibody for use in drug resistant cancers and production thereof |
| 02/11/1992 | CA2048899A1 Reducing chelating agents, their technetium and rhenium complexes, process for their production as well as their use in diagnosis and treatment |
| 02/11/1992 | CA1295786C Cytotoxic substances from the marine cyanophyte hormothamnion enteromorphoides grunow |
| 02/11/1992 | CA1295612C Nitrogen containing derivatives of epipodophyllotoxin glucosides |
| 02/11/1992 | CA1295567C Expression system for the secretion of bioactive human granulocyte, macrophage-colony stimulating factor (gm-csf) and other heterologous proteins from streptomyces |
| 02/10/1992 | WO1992002641A1 Psoralen conjugated methylphosphonate oligonucleotides as therapeutic agents for chronic myelogenous leukemia |
| 02/10/1992 | CA2089088A1 Psoralen conjugated methylphosphonate oligonucleotides as therapeutic agents for chronic myelogenous leukemia |
| 02/09/1992 | WO1992002208A1 Stable doxorubicin/liposome composition |
| 02/09/1992 | CA2088975A1 Stable doxorubicin/liposome composition |
| 02/06/1992 | WO1992001803A1 Method for hydroxylation of a cyclic or acyclic methylene radical in the allylic position, pharmaceutical composition containing hydroxycholesterol derivatives and utilisation of such compositions for the preparation of drugs |
| 02/06/1992 | WO1992001718A2 Functionally active selectin-derived peptides and ligand for gmp-140 |
| 02/06/1992 | WO1992001470A1 Target specific antibody-superantigen conjugates and their preparation |
| 02/06/1992 | DE4124481A1 Solid oral ifosfamide dosage forms |
| 02/05/1992 | EP0469813A2 Use of zwitterionic compounds and their N-halo derivatives |
| 02/05/1992 | EP0469440A1 Solid oral administration forms containing ifosfamide as active agent |
| 02/05/1992 | EP0191772B1 Acid-cleavable compound |
| 02/05/1992 | CN1058401A Antitumor compositions and methods of treatment |
| 02/04/1992 | WO1992004895A1 Enhancement of glutathione levels with glutamine |
| 02/04/1992 | US5086059 Bis-naphthalimides as anticancer agents |
| 02/04/1992 | CA1295326C Anthracycline derivatives and processes for the production thereof |
| 02/04/1992 | CA1295269C Polynucleotide analogs, methods for inhibiting nucleic acid polymerases and methods for inducing synthesis of interferon |
| 02/04/1992 | CA1295243C Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon |
| 02/04/1992 | CA1295241C Lymphokine and its production and uses |
| 02/02/1992 | WO1992002480A1 Golfomycin derivatives: novel fused ring cyclodecadiyne derivatives |
| 02/02/1992 | WO1992002227A1 Phosphene oxide-terminated allene-ene-yne dna-cleaving, antitumor and antibiotic molecules |
| 02/02/1992 | CA2088499A1 Dynemicin analogs: syntheses, methods of preparation and use |
| 02/02/1992 | CA2088498A1 Golfomycin derivatives: novel fused ring cyclodecadiyne derivatives |
| 02/02/1992 | CA2085599A1 Phosphene oxide-terminated allene-ene-yne dna-cleaving, antitumor and antibiotic molecules |
| 02/01/1992 | WO1992002545A1 Bombesin antagonists |
| 02/01/1992 | CA2088166A1 Peptides |
| 01/31/1992 | CA2048068A1 Zwitterionic compounds and their n-halo derivatives for use in the treatment of clinical conditions |
| 01/29/1992 | EP0468637A1 In vivo targeting with bifunctional antibodies |
| 01/29/1992 | EP0468497A2 Peptide-antagonists of bombesin/GRP |
| 01/29/1992 | EP0468393A1 Process for the extraction and purification of human recombinant gamma interferon |
| 01/29/1992 | EP0468231A2 Guanidins |
| 01/29/1992 | EP0467932A1 Urokinase-type plasminogen activator receptor |
| 01/29/1992 | CN1058208A Pharmaceutical compounds |
| 01/28/1992 | US5084555 Anticarcinogenic agents, gastrointestinal disorders and diabetic agents |
| 01/28/1992 | US5084466 Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
| 01/28/1992 | US5084464 Conjugated γ-hydroxybutenolide compounds and antiulcer agents containing the same as an effective ingredient |
| 01/28/1992 | US5084450 Progestomimetic and antiesterogenic steroids for animals |
| 01/28/1992 | CA1294957C Anthracycline derivatives, uses thereof as antitumor agent and production thereof |
| 01/28/1992 | CA1294911C Antitumor agent obtained by microbial stereoselective reduction of 4'-deoxy-4'-iododoxorubicin |
| 01/28/1992 | CA1294874C Composition for inhibiting tumor growth |
| 01/26/1992 | CA2047769A1 Process for the extraction and purification of human recombinant gamma interferon |
| 01/24/1992 | CA2047540A1 Continuous release pharmaceutical compositions |
| 01/23/1992 | WO1992001059A1 Cdr grafted anti-cea antibodies and their production |
| 01/23/1992 | WO1992001000A1 Basophil granule proteins |
| 01/23/1992 | WO1992000971A1 Water-soluble bis-dioxopiperazine derivative |
| 01/23/1992 | WO1992000960A1 Beta-alethine use in cell culture and therapy |
| 01/23/1992 | WO1992000955A1 Vitaletheine and use in cell culture and therapy |
| 01/23/1992 | WO1992000758A1 Method of preparing a radioactive rhenium complex solution |
| 01/23/1992 | WO1992000757A1 Diagnosis of metastatic cancer by the mts-1 gene |
| 01/23/1992 | WO1992000743A1 Use of taurolidine and/or taurultam for the treatment of tumours |
| 01/23/1992 | CA2086932A1 Basophil granule proteins |
| 01/23/1992 | CA2086829A1 Diagnosis of metastatic cancer by the mts-1 gene |
| 01/23/1992 | CA2065291A1 Water soluble bis-dioxopiperazine derivatives |
| 01/22/1992 | EP0467795A2 Dermatological or cosmetic compositions containing vitamin A derivatives |
| 01/22/1992 | EP0467621A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them |
| 01/22/1992 | EP0467613A1 Antitumor compositions and methods of treatment |
| 01/22/1992 | EP0467606A1 Rapamycin derivatives |
| 01/22/1992 | EP0467536A2 Method of treating bladder cancer cells |
| 01/22/1992 | EP0467366A2 Cell membrane glycoprotein correlated with resistance to platinum-containing antineoplastic agents |
| 01/22/1992 | EP0467275A1 Liposomal products |
| 01/22/1992 | EP0466813A1 Active specific immunotherapy of adenocarcinomas producing immunosuppressive mucins |
| 01/22/1992 | CN1058021A 9-purinyl phosphonic acid derivatives |